Skip to main content

Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome.

  • 2005-11
  • FEMS Microbiology Letters 252(1)
    • P. Kelly
    • Patricia B. Maguire
    • M. Bennett
    • Desmond J. Fitzgerald
    • Richard J. Edwards
    • B. Thiede
    • A. Treumann
    • J. Kevin Collins
    • Gerald C. O'sullivan
    • F. Shanahan
    • C. Dunne

Abstract

Lactobacillus salivarius subsp. salivarius UCC118 is a probiotic bacterium that was originally isolated from human intestinal tissues and was subsequently shown in a pilot study to alleviate symptoms associated with mild-moderate Crohn's disease. Strain UCC118 can adhere to animal and human intestinal tissue, and to both healthy and inflamed ulcerative colitis mucosa, irrespective of location in the gut. In this study, an enzymatic technique has been combined with proteomic analysis to correlate bacterial growth phase with the presence of factors present in the cell wall of the bacterium. Using PAGE electrophoresis, it was determined that progression from lag to log to stationary growth phases in vitro correlated with increasing prominence of an 84kD protein associated with in vitro adherence ability. Isolated proteins from the 84kD band region were further separated by two-dimensional electrophoresis, resolving this band into 20 individual protein spots at differing isoelectric points. The protein moieties were excised, trypsin digested and subjected to tandem mass spectrometry. The observed proteins are analogous to those reported to be associated with the Listeria monocytogenes cell-wall proteome, and include DnaK, Ef-Ts and pyruvate kinase. These data suggest that at least some of the beneficial attributes of probiotic lactobacilli, and in particular this strain, may be due to nonpathogenic mimicry of pathogens and potentially be mediated through a form of attenuated virulence.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus salivarius CRL 1328Alleviated Symptoms of Mild to Moderate Crohn's DiseaseBeneficial
Moderate
Lactobacillus salivarius SD-5208Alleviated Symptoms of Mild to Moderate Crohn's DiseaseBeneficial
Moderate
Lactobacillus salivarius UCC118Reduced Crohn's Disease SymptomsBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.